healthcare
HeadlinesGenmab to Buy Dutch Cancer Drugmaker Merus for $8 Billion
UK to Offer to Pay More for Some Drugs to Appease Trump, Ft Reports
US NIH's $50 Million Autism Initiative Grounded in Science
HeadlinesFemale Prisoner Dies in Iran; Rights Groups Blame Delayed Medical Treatment
Philips in Talks With US Over Probes of Medical Technology Imports
Date: September 25, 2025
(Reuters) -Philips is actively engaged with policymakers in Washington about investigations into U.S. imports of medical technology items but does not expect an immediate impact from the probes, it...
European Shares Touch Three-Week Low as Med-Tech Hit by US Import Probes
Date: September 25, 2025
(Reuters) -European shares eased on Thursday as losses in healthcare and industrials weighed early on, with focus on comments from a spate of U.S. Federal Reserve policymakers and data due later in...
Private Detectives Tail French Workers to Root Out Surging Sick Leave Fraud
Date: September 25, 2025
By Gabriel Stargardter PARIS (Reuters) -Fabrice Lehmann caught sight of his target as he left his suburban Paris home, dressed for work. He began tailing him, trying to blend in with the commuters...
Attorneys Urge Court Overseeing Tylenol Autism Lawsuits to Consider Trump Administration's Stance
Date: September 25, 2025
By Diana Novak Jones (Reuters) -Families appealing the dismissal of their lawsuits alleging that Kenvue's Tylenol or generic versions of the pain-relief medication caused their children's autism are...
French Court Orders Sanofi to Pay $177 Million for Anti-Competitive Behaviour
Date: September 24, 2025
(Reuters) -A Paris court on Wednesday ordered Sanofi and its Winthrop unit to pay 150.7 million euros ($177.1 million) in damages to France's national health insurance fund (CNAM) for anti-competitive...
Eli Lilly's Boss Calls UK the 'worst' European Country for Drug Prices
Date: September 24, 2025
By Muvija M LONDON (Reuters) -Eli Lilly Chief Executive Dave Ricks said Britain was "probably the worst country in Europe" for drug prices in an interview with the Financial Times, intensifying...